KCTD3

KCTD3 is an accessory subunit of the HCN3 ion channel that binds specifically to the HCN3 C-terminus via its own C-terminal half and up-regulates HCN3 cell surface expression and current density, requiring its N-terminal tetramerization domain for this functional effect (PMID:23382386). Domain-swap experiments demonstrate that the HCN3 cytosolic C-terminus is the critical determinant of KCTD3 sensitivity, as replacing the HCN2 C-terminus with that of HCN3 confers KCTD3-mediated current augmentation (PMID:23382386). Biallelic loss-of-function mutations in KCTD3 cause developmental epileptic encephalopathy with cerebellar abnormalities, global developmental delay, and hypotonia (PMID:29406573).

1. 2000 Low

   Before KCTD3's molecular function was known, a yeast two-hybrid screen identified a protein (SB1/NY-REN-45, sharing identity with KCTD3) as an SH3-domain binding partner of the adaptor protein SETA, suggesting KCTD3 participates in protein–protein interactions but leaving its physiological role unresolved.

   Evidence Yeast two-hybrid, in vitro binding, and co-immunoprecipitation with SETA

   PMID:11152963

   Open questions at the time

   • The identity of SB1/NY-REN-45 with KCTD3 is not explicitly confirmed in this study
   • No functional consequence of the SETA–SB1 interaction was demonstrated
   • No independent validation of this interaction has been reported
2. 2013 High

   The key mechanistic question — what ion channel or signaling pathway KCTD3 regulates — was answered by demonstrating that KCTD3 is a specific accessory subunit of HCN3, binding its C-terminus and profoundly enhancing its surface expression and current density through a mechanism requiring KCTD3 tetramerization.

   Evidence Co-immunoprecipitation, heterologous expression electrophysiology, domain-swap mutagenesis, and brain colocalization immunohistochemistry

   PMID:23382386

   Open questions at the time

   • The structural basis of the KCTD3–HCN3 C-terminus interaction has not been resolved
   • The trafficking mechanism by which KCTD3 tetramerization promotes HCN3 surface delivery is unknown
   • In vivo physiological consequences of KCTD3-mediated HCN3 regulation have not been tested in animal models
3. 2018 Medium

   The question of KCTD3's relevance to human disease was resolved when biallelic loss-of-function mutations were shown to cause developmental epileptic encephalopathy with cerebellar abnormalities across multiple families, establishing KCTD3 as essential for normal brain development.

   Evidence Whole exome sequencing with segregation analysis in four consanguineous families (7 affected individuals)

   PMID:29406573

   Open questions at the time

   • No functional rescue or model organism knockout has confirmed causality
   • Whether the disease mechanism involves loss of HCN3 regulation, other KCTD3 functions, or both is unknown
   • The specific contribution of KCTD3 to cerebellar development has not been dissected

• It remains unknown how KCTD3 tetramerization mechanistically promotes HCN3 surface trafficking, whether KCTD3 has HCN3-independent functions in brain or kidney, and whether the epileptic encephalopathy phenotype is directly attributable to impaired HCN3 regulation.
• No structural model of the KCTD3–HCN3 complex exists
• KCTD3 function in kidney, where it is highly expressed, is uncharacterized
• No animal model with KCTD3 loss-of-function has been reported